Natera, Inc. vs Abbvie Inc.
NTRA vs ABBV — side-by-side comparison from reported financials. NTRA leads 3, ABBV leads 5 of 8 comparable metrics.
Natera, Inc.
NTRA · Healthcare
$400.71+2.54%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | NTRA | ABBV |
|---|---|---|
| Price | $400.71 | $276.43 |
| Market cap | $57.8B | $488B |
| Revenue (TTM) | $2.71B | $64.4B |
| Revenue growth | +41.1% | +1.8% |
| Net margin | -7.1% | 9.8% |
| Free cash flow | $84.2M | $18.2B |
| Net cash (debt) | $1.02B | ($56.2B) |
| 1-year price return | +131.6% | +19.8% |
| P/E | — | 77.4 |
| P/E vs own history (cheap-side %) | — | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | -12% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 4 of 9 | 9 of 9 |
| Employees | 6,140 | 57,000 |
Full résumé-style profiles: NTRA CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.